Companies: 49,245 Total Market Cap: 132638112408962.06

Genscript Biotech

HKG-1548
Healthcare Biotechnology
Rank #4716
Market Cap 2.89 B
Volume 16.20 M
Price 1.33
Change (%) 0.19%
Country or region Hong Kong Hong Kong

Genscript Biotech's latest marketcap:

2.89 B

As of 05/20/2025, Genscript Biotech's market capitalization has reached $2.89 B. According to our data, Genscript Biotech is the 4716th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 2.89 B
Revenue (ttm) 589.68 M
Net Income (ttm) 2.94 B
Shares Out 2.17 B
EPS (ttm) 1.38
Forward PE 16.44
Ex-Dividend Date n/a
Earnings Date 05/09/2025
Market Cap Chart
Data Updated: 05/20/2025

Genscript Biotech's yearly market capitalization.

Genscript Biotech has seen its market value grow from HK$22.03 B to HK$22.65 B since 2020, representing a total increase of 2.80% and an annual compound growth rate (CAGR) of 0.63%.
Date Market Cap Change (%)
05/20/2025 HK$22.65 B 4.87%
12/31/2024 HK$21.10 B -49.96%
12/29/2023 HK$42.16 B -19.78%
12/30/2022 HK$52.56 B -27.5%
12/31/2021 HK$72.50 B 229.03%
12/31/2020 HK$22.03 B

Company Profile

About Genscript Biotech Corporation

Genscript Biotech Corporation is an investment holding company specializing in the manufacture and sale of life science research products and services. The company operates globally, serving markets in the United States, Europe, Mainland China, Asia Pacific, and other international regions.

Business Segments

Genscript Biotech operates through three key segments:

  • Life Science Services and Products: Offers gene synthesis, oligonucleotide synthesis, peptide synthesis, protein engineering, antibody development, and life-science equipment. These products and services support biology studies, pharmaceutical research, diagnostics, agriculture, and environmental studies.
  • Biologics Development Services: Provides an integrated platform to accelerate the development of therapeutic antibodies, gene therapy, and cell therapy products for biopharmaceutical and biotech companies.
  • Industrial Synthetic Biology Products: Focuses on developing and producing industrial enzymes using genetic engineering techniques with non-pathogenic microbial strains.

Company Background

Founded in 2002, Genscript Biotech Corporation is headquartered in Nanjing, the People’s Republic of China. The company has established itself as a leader in life science innovation, catering to diverse industries worldwide.

Frequently Asked Questions

As of 05/20/2025, Genscript Biotech (including the parent company, if applicable) has an estimated market capitalization of $2.89 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Genscript Biotech global market capitalization ranking is approximately 4716 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Hong Kong
Founded 2002
IPO Date n/a
Employees 5,568
CEO Weihui Shao
Sector Healthcare
Industry Biotechnology
Address Jiangning Science Park
Nanjing, 211100
China
Website https://www.genscript.com
People Also Watch
VRTX
440.66 0.15%
CSL Limited
156.61 0.15%
REGN
596.54 0.15%
KRX-207940
732.25 0.15%